Retrospective analysis of liver cirrhosis influence on heart walls thickness

Jakub Wroński1, Piotr Fiedor2, Monika Kwolczak3

  • 1Students Scientific Group at Department of Pathology, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warszawa, Poland; Students Scientific Group at Department of General and Transplantation Surgery, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warszawa, Poland.

Insights

Liver cirrhosis can cause heart wall changes, including left ventricular thickening and right ventricular thinning. These cardiac alterations are linked to increased cardiocirculatory failure deaths in patients without hypertension.

Area of Science:

  • Cardiology
  • Pathology
  • Hepatology

Background:

  • Cirrhotic cardiomyopathy is a known cardiac dysfunction in liver cirrhosis patients.
  • While impaired cardiac function is common, anatomical myocardial changes are also observed.
  • This study focuses on cirrhotic patients without a history of hypertension.

Purpose of the Study:

  • To investigate the impact of liver cirrhosis on heart wall thickness.
  • To analyze pathological changes in the myocardium of cirrhotic individuals.
  • To correlate cardiac anatomical changes with clinical outcomes and causes of death.

Main Methods:

  • Retrospective analysis of 11,860 autopsy protocols from 1981-2002.
  • Statistical analysis of heart wall thickness in patients with and without hypertension.
  • Identification of specific myocardial changes: left ventricular thickening, right ventricular thinning.

Main Results:

  • Liver cirrhosis was present in 6.7% of autopsy cases; hypertension was excluded in 697 patients.
  • Pathological heart wall changes occurred in 53.2% of cirrhotic patients.
  • Left ventricular thickening (9.3%), right ventricular thinning (31.0%), and both (12.9%) were observed. Cardiocirculatory failure was a significant cause of death, especially with left ventricular thickening.

Conclusions:

  • Liver cirrhosis can induce significant heart wall thickness changes, including left ventricular hypertrophy and right ventricular thinning.
  • Selective left ventricular thickening is associated with a higher incidence of cardiac-related mortality.
  • Management of cirrhotic cardiomyopathy necessitates integrated cardiological and hepatological care, particularly for patients with left ventricular hypertrophy.
Abstract